While injection site discomfort is typically minimal and transient, GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists are associated with other side effects that patients should understand before starting treatment
Ivanov AV, Bartosch B, Isaguliants MG
Importantly, these medications are not recommended for patients with severe gastrointestinal disease, including gastroparesis, due to their effects on gastric emptying
Benefits may include improved sleep quality, faster recovery, better body composition, increased energy, and enhanced fat metabolism
Lastly, Glutathione S-transferases mu 1 (GSTM1) and theta 1 (GSTT1) are Phase II enzymes that aid in detoxifying harmful electrophilic compounds
Design, Setting, and Participants KET01-03 was an active-comparator, double-blind, double-dummy, crossover phase 1 randomized clinical trial (RCT) conducted among healthy adult male volunteers (aged 18 years) between July and August 2023 at a single trial site in Germany